It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2018.
2018 | Aurangabad, Maharashtra, India | ActiveAtaraxia Pharma Private Limited, a active private limited company, was established on 17 October 2018 in Aurangabad, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2018PTC315902. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Its leadership includes Sani Malose (Director), Akshay Anilrao Dalal (Director). Past directors included Avinash Bhaskarrao Malose, Akshay Anilrao Dalal. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O M/S Empire Mall Private Limited, Plot No P-80 , Iind Floor, Gala No B-3-A,, Midc, Chikalthana Industrial Area, Chh. Sambhaji Nagar, (Aurangabad), Aurangabad, Maharashtra, 431007.
U74999MH2018PTC315902
315902
17 October 2018
₹1.50 M
₹1.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ataraxia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sani Malose | Director | 17 Oct 2018 | Current |
| Akshay Anilrao Dalal | Director | 29 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ataraxia Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 689.76% increase. The company also saw a substantial improvement in profitability, with a 233.46% increase in profit. The company's net worth Soared by an impressive increase of 203.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ataraxia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2024 | Others | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ataraxia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ataraxia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ataraxia Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ataraxia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Others amounted to Rs. 15.00 M with Charge ID 100971132 was registered on 05 Sep 2024. was completed.
Progress on Ataraxia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Akshay Anilrao Dalal was appointed as a Director was appointed as a Director on 29 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
The activity Sani Malose was appointed as a Director was appointed as a Director on 17 Oct 2018 & has been associated with this company since 7 years 2 months . was completed.
Progress on Ataraxia Pharma Private Limited was registered on 17 Oct 2018 with Roc Mumbai & aged 7 years 2 months as per MCA records. was documented.
The CIN of Ataraxia Pharma Private Limited is U74999MH2018PTC315902.
Ataraxia Pharma Private Limited is headquartered at C/O M/S Empire Mall Private Limited, Plot No P-80 , Iind Floor, Gala No B-3-A,, Midc, Chikalthana Industrial Area, Chh. Sambhaji Nagar, (Aurangabad), Aurangabad, Maharashtra, 431007.
Ataraxia Pharma Private Limited was incorporated on 17 October 2018.
The current directors of Ataraxia Pharma Private Limited are
The primary industry of Ataraxia Pharma Private Limited is Trade.
Ataraxia Pharma Private Limited is unlisted.
The authorized capital of Ataraxia Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.10 M.
The compliance status of Ataraxia Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX